FBInvestor
Stocks / Opus Genetics Inc
Institutional Ownership

Opus Genetics Inc

CUSIP 67577R102COMIRDQ1 2026

13D / 13G Filings
21
Schedule 13D/13G on record
Beneficial Filers
9
Distinct reporting persons
Largest Stake
15.9%
Max % of class reported
Institutional Holders
76
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

21 filings · latest Feb 17, 2026

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Feb 17, 2026Perceptive Advisors LLC13G/A10.0%7.17MSEC
2Feb 17, 2026Balyasny Asset Management L.P.13G7.4%5.11MSEC
3Feb 13, 2026Nantahala Capital Management, LLC13G/A10.0%7.12MSEC
4Dec 11, 2025Foundation Fighting Blindness Retinal Degeneration Fund13D/A8.0%SEC
5Aug 14, 2025Nantahala Capital Management, LLC13G/A10.0%6.25MSEC
6May 15, 2025Nantahala Capital Management, LLC13G10.0%4.70MSEC
7May 6, 2025Foundation Fighting Blindness Retinal Degeneration Fund13D/A15.9%SEC
8Mar 31, 2025Perceptive Advisors LLC13G10.0%4.51MSEC
9Oct 29, 2024Foundation Fighting Blindness Retinal Degeneration Fund13D8.2%2.56MSEC
10Feb 14, 2023Sooch Mina13G/A5.5%1.19MSEC

11 more beneficial-ownership filings on Premium

See the full Schedule 13D/13G history for Opus Genetics Inc.

Unlock full history

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →